West Pharmaceutical Services, Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Eric Green
- Full Time Employees
- 10,600
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Address
- 530 Herman O. West Drive Exton PA United States of America 19341-0645
- IPO Date
- Mar 17, 1980
- CIK
- 0000105770
- Website
- westpharma.com
- Similar Companies
- Business
- West Pharmaceutical Services, Inc. is a global manufacturer and provider of integrated containment and delivery systems primarily for injectable drugs and healthcare products. The company's core offerings include stoppers and seals for injectable packaging systems; syringe and cartridge components; self-injection devices featuring patient-centric, connected health technologies; and advanced containment and delivery solutions such as the proprietary Daikyo Crystal Zenith polymer, a high-performance glass alternative suited for sensitive biologics. West also provides contract manufacturing services encompassing injection molding, contract assembly, and finished packaging through facilities in North America and Europe. Founded in 1923, the company is headquartered in Exton, Pennsylvania, and serves pharmaceutical, biologics, vaccine, and consumer healthcare markets worldwide. Recent major strategic developments at West include the launch of the West Synchrony™ Prefillable Syringe System, an innovative, fully verified system-level product designed specifically for biologics and vaccines scheduled for commercial availability in 2026. This system integrates syringe barrel, plunger, and needle components into a harmonized platform that accelerates regulatory submission and enhances supply chain reliability. In addition, West has strengthened its collaboration with Corning Incorporated, combining West’s NovaPure components and Daikyo Flurotec coating technology with Corning’s Valor® Glass and Velocity® Vials to develop advanced pharmaceutical packaging solutions that improve patient safety and drug stability. Furthermore, West has made a strategic investment in Latch Medical, a Dublin-based company specializing in next-generation vaccine and biologics delivery technology focused on intradermal delivery. West operates across more than 50 sites worldwide, including 25 manufacturing locations, supporting its expansive global supply chain. The company reported $2.89 billion in net sales for fiscal year 2024 and is publicly traded on the New York Stock Exchange under the ticker WST. It is also included in the Standard & Poor’s 500 index, reflecting its prominence as a trusted partner to established and emerging drug developers for the safe containment and delivery of life-saving medicines on a global scale. This comprehensive integration of innovative product offerings and strategic partnerships underscores West Pharmaceutical Services’ position as a leader in injectable drug delivery systems, supported by a nearly century-long heritage of technological advancement and manufacturing excellence.
WST Stock Up Nearly 33% YTD: Will the Uptrend Continue in the Rest of 2026?
West Completes Sale and Transfer of the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System
MMSI or WST: Which Is the Better Value Stock Right Now?
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Cerebras Systems, Cleveland-Cliffs, Equity Residential, FuelCell Energy, Lennar, Luckin Coffee, Toll Brothers, and More
Top 50 High-Quality Dividend Growth Stocks For June 2026
West Pharmaceutical Services, Inc. (WST) Presents at 46th Annual William Blair Growth Stock Conference Prepared Remarks Transcript
Billionaire Bill Gates' Foundation Dumped Microsoft but Loaded Up on This Dividend Champion
West Pharma names former Thermo Fisher executive Lagarde as CEO
West Appoints Michel Lagarde to be President and Chief Executive Officer
A Look at West Pharmaceutical Services Inc (WST) After 3.5% Gain -- GF Value $359.79 vs Price $316.13
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now
West Pharma says fully operational after cyberattack, sees no hit to 2026 forecast
West Pharma says operations recovering after cyberattack
West Pharmaceutical Services, Inc. (WST) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Investors Await Damage Assessment After West Pharmaceutical Cyberattack
ALGN vs. WST: Which Stock Is the Better Value Option?
West Pharmaceutical Services, Inc. (WST) Hit a 52 Week High, Can the Run Continue?
West Pharmaceutical Services (WST) Just Flashed Golden Cross Signal: Do You Buy?
West Pharmaceutical: Multiple Growth Drivers Are A Tailwind
West Pharmaceutical Services, Inc. $WST Shares Purchased by Comerica Bank